Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D003609:Dactinomycin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D005472:Fluorouracil / Q000494:pharmacology; D006918:Hydroxyurea / Q000494:pharmacology; D007700:Kinetics; D008545:Melanoma / Q000378:metabolism*; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism; D011454:Prostaglandins A / Q000494:pharmacology*
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D011454:Prostaglandins A; D003609:Dactinomycin; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D006918:Hydroxyurea